Thomas Werfel

27.3k total citations · 5 hit papers
285 papers, 12.4k citations indexed

About

Thomas Werfel is a scholar working on Dermatology, Immunology and Allergy and Immunology. According to data from OpenAlex, Thomas Werfel has authored 285 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 201 papers in Dermatology, 174 papers in Immunology and Allergy and 104 papers in Immunology. Recurrent topics in Thomas Werfel's work include Dermatology and Skin Diseases (191 papers), Allergic Rhinitis and Sensitization (147 papers) and Asthma and respiratory diseases (89 papers). Thomas Werfel is often cited by papers focused on Dermatology and Skin Diseases (191 papers), Allergic Rhinitis and Sensitization (147 papers) and Asthma and respiratory diseases (89 papers). Thomas Werfel collaborates with scholars based in Germany, United States and United Kingdom. Thomas Werfel's co-authors include Alexander Kapp, Miriam Wittmann, Ralf Gutzmer, Margarete Niebuhr, Kristine Breuer, Susanne Mommert, Sadaf Kasraie, Annice Heratizadeh, Holger Stark and Johannes Ring and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Thomas Werfel

278 papers receiving 12.0k citations

Hit Papers

Consensus‐based European guidelines for treatment of atop... 2016 2026 2019 2022 2018 2016 2016 2016 2021 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Werfel Germany 63 8.1k 6.5k 3.8k 3.4k 1.8k 285 12.4k
Andreas Wollenberg Germany 54 8.5k 1.1× 6.1k 0.9× 2.5k 0.7× 2.8k 0.8× 1.7k 1.0× 320 12.0k
Mark Boguniewicz United States 59 13.4k 1.6× 10.1k 1.6× 3.2k 0.8× 4.7k 1.4× 1.7k 1.0× 225 16.6k
Natalija Novak Germany 54 6.0k 0.7× 5.6k 0.9× 3.1k 0.8× 3.3k 1.0× 889 0.5× 221 11.4k
Lisa A. Beck United States 54 6.8k 0.8× 5.5k 0.9× 3.1k 0.8× 3.4k 1.0× 2.0k 1.1× 237 12.5k
Alan D. Irvine Ireland 58 11.5k 1.4× 8.3k 1.3× 2.2k 0.6× 3.8k 1.1× 1.4k 0.8× 298 17.2k
Peter Schmid‐Grendelmeier Switzerland 47 4.4k 0.5× 4.5k 0.7× 1.5k 0.4× 2.6k 0.8× 2.1k 1.2× 213 8.8k
Alexander Kapp Germany 73 6.9k 0.8× 6.5k 1.0× 4.5k 1.2× 4.6k 1.4× 3.6k 2.0× 408 16.3k
Edward F. Knol Netherlands 53 3.3k 0.4× 5.3k 0.8× 2.3k 0.6× 2.6k 0.8× 904 0.5× 196 8.9k
Kristian Thestrup‐Pedersen Denmark 43 6.0k 0.7× 3.8k 0.6× 2.4k 0.6× 2.0k 0.6× 764 0.4× 199 9.2k
Jan D. Bos Netherlands 50 4.4k 0.5× 1.6k 0.3× 4.4k 1.2× 1.0k 0.3× 1.1k 0.6× 131 9.3k

Countries citing papers authored by Thomas Werfel

Since Specialization
Citations

This map shows the geographic impact of Thomas Werfel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Werfel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Werfel more than expected).

Fields of papers citing papers by Thomas Werfel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Werfel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Werfel. The network helps show where Thomas Werfel may publish in the future.

Co-authorship network of co-authors of Thomas Werfel

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Werfel. A scholar is included among the top collaborators of Thomas Werfel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Werfel. Thomas Werfel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeitvogel, Jana, Stephan Traidl, Elke Rodríguez, et al.. (2025). Collagen XXIII (COL23A1): A novel risk factor for eczema herpeticum. Journal of Allergy and Clinical Immunology. 156(5). 1247–1259. 1 indexed citations
2.
Roesner, Lennart M., Manoj Kumar Gupta, Verena Kopfnagel, et al.. (2024). The RESIST Senior Individuals Cohort: Design, participant characteristics and aims. GeroScience. 47(3). 3299–3310. 2 indexed citations
3.
Nikolouli, Eirini, Susanne Mommert, Holger Stark, et al.. (2024). The stimulation of TH2 cells results in increased IL‐5 and IL‐13 production via the H4 receptor. Allergy. 79(8). 2186–2196. 2 indexed citations
4.
Zeitvogel, Jana, et al.. (2024). Short‐form thymic stromal lymphopoietin (sfTSLP) restricts herpes simplex virus infection of human primary keratinocytes. Journal of Medical Virology. 96(9). 3 indexed citations
5.
Begemann, Gabriele, et al.. (2023). Inhibition of IL-17 ameliorates keratinocyte-borne cytokine responses in an in vitro model for house-dust-mite triggered atopic dermatitis. Scientific Reports. 13(1). 16628–16628. 4 indexed citations
6.
Buhl, Timo & Thomas Werfel. (2023). Atopic dermatitis – Perspectives and unmet medical needs. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 21(4). 349–353. 11 indexed citations
7.
Fries, Anissa, Fanny Saidoune, François Kuonen, et al.. (2023). Differentiation of IL-26+ TH17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis. Nature Communications. 14(1). 3878–3878. 32 indexed citations
8.
Reich, Kristian, Jonathan I. Silverberg, Kim Papp, et al.. (2023). Abrocitinib effect on patient‐reported outcomes in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study. Journal of the European Academy of Dermatology and Venereology. 37(10). 2047–2055. 5 indexed citations
9.
Traidl, Stephan, et al.. (2023). Dupilumab strengthens herpes simplex virus type 1–specific immune responses in atopic dermatitis. Journal of Allergy and Clinical Immunology. 152(6). 1460–1469.e5. 11 indexed citations
10.
Reich, Kristian, Jonathan I. Silverberg, Kim Papp, et al.. (2023). Abrocitinib efficacy and safety in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study. Journal of the European Academy of Dermatology and Venereology. 37(10). 2056–2066. 20 indexed citations
11.
Zhang, Bowen, Lennart M. Roesner, Stephan Traidl, et al.. (2022). Single‐cell profiles reveal distinctive immune response in atopic dermatitis in contrast to psoriasis. Allergy. 78(2). 439–453. 52 indexed citations
12.
Traidl, Stephan, Lennart M. Roesner, Jana Zeitvogel, & Thomas Werfel. (2021). Eczema herpeticum in atopic dermatitis. Allergy. 76(10). 3017–3027. 46 indexed citations
13.
Luger, Thomas A., Matthias Augustin, Julien Lambert, et al.. (2020). Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus. Pediatric Allergy and Immunology. 32(3). 414–424. 9 indexed citations
14.
Möbus, Lena, Elke Rodríguez, Inken Harder, et al.. (2020). Atopic dermatitis displays stable and dynamic skin transcriptome signatures. Journal of Allergy and Clinical Immunology. 147(1). 213–223. 85 indexed citations
15.
Agache, Ioana, Cezmi A. Akdiş, Mübeccel Akdiş, et al.. (2020). EAACI Biologicals Guidelines—dupilumab for children and adults with moderate‐to‐severe atopic dermatitis. Allergy. 76(4). 988–1009. 25 indexed citations
16.
Alexander, Helen, Amy S. Paller, Claudia Traidl‐Hoffmann, et al.. (2019). The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group. British Journal of Dermatology. 182(6). 1331–1342. 123 indexed citations
17.
Roesner, Lennart M., Stefan Floess, T Witte, et al.. (2015). Foxp3 + regulatory T cells are expanded in severe atopic dermatitis patients. Allergy. 70(12). 1656–1660. 44 indexed citations
18.
Gschwandtner, Maria, Michael Mildner, Veronika Mlitz, et al.. (2012). Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model. Allergy. 68(1). 37–47. 142 indexed citations
19.
Gschwandtner, Maria, Kristine Roßbach, Dorothea Dijkstra, et al.. (2009). Murine and human Langerhans cells express a functional histamine H4 receptor: modulation of cell migration and function. Allergy. 65(7). 840–849. 49 indexed citations
20.
Purwar, Rahul, Miriam Wittmann, Jörg Zwirner, et al.. (2006). Induction of C3 and CCL2 by C3a in Keratinocytes: A Novel Autocrine Amplification Loop of Inflammatory Skin Reactions. The Journal of Immunology. 177(7). 4444–4450. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026